ftc.gov
FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman
Caremark agreed to proposed settlement terms requiring changes to rebate practices, patient costs, pharmacy access and transparency in the FTC’s insulin pricing case.
